This depends on the sample but can include; patient characteristics, Spirometry (FEV1), medication including long-term antibiotics, sample type, clinical state and microbiological status.
Building enabling tools and resources for CF antimicrobial and diagnostic development.
With our funding, we offer a collaborative approach to project development and delivery.
Facilitating knowledge exchange and collaboration across the sector.
Learn more about the CF AMR Syndicate and the work we do.
Building enabling tools and resources for CF antimicrobial and diagnostic development.
With our funding, we offer a collaborative approach to project development and delivery.
Facilitating knowledge exchange and collaboration across the sector.
Learn more about the CF AMR Syndicate and the work we do.